Retracted: rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis

Ming‐Yi Lv, Shu‐Ling Deng, Xiao‐Feng Long

Open source

DOI
10.1111/bcp.12788
Published
2015-11-28
Container
British Journal of Clinical Pharmacology
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcp.12788,
  title = {Retracted: rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis},
  author = {Ming‐Yi Lv and Shu‐Ling Deng and Xiao‐Feng Long},
  year = {2015},
  journal = {British Journal of Clinical Pharmacology},
  doi = {10.1111/bcp.12788},
  url = {https://doi.org/10.1111/bcp.12788}
}

RIS

TY  - JOUR
TI  - Retracted: rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis
AU  - Ming‐Yi Lv
AU  - Shu‐Ling Deng
AU  - Xiao‐Feng Long
PY  - 2015
JO  - British Journal of Clinical Pharmacology
DO  - 10.1111/bcp.12788
UR  - https://doi.org/10.1111/bcp.12788
ER  - 

APA

Lv, M., Deng, S., & Long, X. (2015). Retracted: rhBNP therapy can improve clinical outcomes and reduce in‐hospital mortality compared with dobutamine in heart failure patients: a meta‐analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.12788

Source records